Cite

HARVARD Citation

    Merlo, D. et al. (2019). The feasibility, reliability and concurrent validity of the MSReactor computerized cognitive screening tool in multiple sclerosis. Therapeutic advances in neurological disorders. p. . [Online]. 
  
Back to record